Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online before print July 5, 2006, doi:10.1212/01.wnl.0000227187.52002.88)
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
01.wnl.0000227187.52002.88v1
67/5/771    most recent
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Related articles in Neurology
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Saeed, M.
Right arrow Articles by Siddique, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Saeed, M.
Right arrow Articles by Siddique, T.
Related Collections
Right arrow Neuroendocrinology
Right arrow Association studies in genetics
NEUROLOGY 2006;67:771-776
© 2006 American Academy of Neurology

Paraoxonase cluster polymorphisms are associated with sporadic ALS

M. Saeed, MD, N. Siddique, RN, MSN, W. Y. Hung, PhD, E. Usacheva, PhD, E. Liu, MD, R. L. Sufit, MD, S. L. Heller, MD, J. L. Haines, PhD, M. Pericak-Vance, PhD and T. Siddique, MD

From the Davee Department of Neurology and Clinical Neurosciences (M.S., N.S., W.-Y.H., E.U., E.L., R.L.S., S.L.H.), Feinberg School of Medicine, Northwestern University, Chicago, IL; Center for Human Genetics Research (J.L.H.), Vanderbilt University Medical Center, Nashville, TN; Center for Human Genetics (M.P.-V.), Duke University Medical Center, Durham, NC; and Department of Cell and Molecular Biology (T.S.), Northwestern University Institute of Neuroscience, Chicago, IL.

Address correspondence and reprint requests to Dr. Teepu Siddique, Davee Department of Neurology and Clinical Neurosciences and Department of Cell and Molecular Biology, Northwestern University Feinberg School of Medicine, Tarry Building, Room 13-715, 303 East Chicago Avenue, Chicago IL 60611; e-mail: t-siddique{at}northwestern.edu

Background: Paraoxonases (PONs) are involved in the detoxification of organophosphate pesticides and chemical nerve agents. Due to a reported possible twofold increased risk of ALS in Gulf War veterans and the associations of PON1 polymorphisms with the neurologic symptom complex of the Gulf War syndrome, the authors investigated the association between sporadic ALS (SALS) and PON gene cluster variants in a large North American Caucasian family–based and case-control cohort (N = 1,891).

Methods: Clinically definite and probable ALS was diagnosed according to the revised El Escorial criteria, exclusion of family history of ALS, and SOD1 mutation analysis. Single nucleotide polymorphism (SNP) genotyping was done using TaqMan assays on ABI7900HT. Data were analyzed using SPSS, Haploview, FBAT, and THESIAS.

Results: A haploblock of high linkage disequilibrium (LD) spanning PON2 and PON3 was associated with SALS. The SNPs rs10487132 and rs11981433 were in strong LD and associated with SALS in the trio (parents-affected child triad) model. The association of rs10487132 was replicated in 450 nuclear pedigrees comprising trios and discordant sibpairs. No association was found in case-control models, and their haplostructure was different from that of the trios with overall reduced LD. Resequencing identified an intronic variant (rs17876088) that differentiated between detrimental and protective SALS haplotypes.

Conclusion: This study demonstrates evidence of significant association of variants in the Paraoxonase gene cluster with sporadic ALS and is compatible with the hypothesis that environmental toxicity in a susceptible host may precipitate ALS.


Additional material related to this article can be found on the Neurology Web site. Go to www.neurology.org and scroll down the Table of Contents for the September 12 issue to find the title link for this article.

Editorial, see page 738

See also page 766

This article was previously published in electronic format as an Expedited E-Pub on July 5, 2006, atwww.neurology.org.

Supported by the National Institute of Neurological Disorders and Stroke (NS050641, NS046535), the Les Turner ALS Foundation, the V. E. Schaff ALS Research Fund, the H. Post Research Professorship, the Wenske Foundation, the Falk Medical Research Trust, Abbott Labs Duane and Susan Burnham Professorship, and the David C. Asselin MD Memorial Fund.

Disclosure: The authors report no conflicts of interest

Received January 23, 2006. Accepted in final form April 25, 2006.


Related articles in Neurology:

September 12 Highlights

Neurology 2006 67: 734-735. [Full Text]  

Susceptibility genes in sporadic ALS: Separating the wheat from the chaff by international collaboration
Christopher E. Shaw and Ammar Al-Chalabi
Neurology 2006 67: 738-739. [Full Text]  

Paraoxonase gene polymorphisms and sporadic ALS
A. Slowik, B. Tomik, P. P. Wolkow, D. Partyka, W. Turaj, M. T. Malecki, J. Pera, T. Dziedzic, A. Szczudlik, and D. A. Figlewicz
Neurology 2006 67: 766-770. [Abstract] [Full Text]  



This article has been cited by other articles:


Home page
NeurologyHome page
A. -M. Wills, J. E. Landers, H. Zhang, R. J. Richter, A. J. Caraganis, M. E. Cudkowicz, C. E. Furlong, and R. H. Brown Jr
Paraoxonase 1 (PON1) organophosphate hydrolysis is not reduced in ALS
Neurology, March 18, 2008; 70(12): 929 - 934.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
B. A. Golomb
Acetylcholinesterase inhibitors and Gulf War illnesses
PNAS, March 18, 2008; 105(11): 4295 - 4300.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
J.C. Schymick, K. Talbot, and B.J. Traynor
Genetics of sporadic amyotrophic lateral sclerosis
Hum. Mol. Genet., October 15, 2007; 16(R2): R233 - R242.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
N. A. Sutedja, J. H. Veldink, K. Fischer, H. Kromhout, J.H.J. Wokke, M. H.B. Huisman, D. J.J. Heederik, and L. H. Van den Berg
Lifetime occupation, education, smoking, and risk of ALS
Neurology, October 9, 2007; 69(15): 1508 - 1514.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
S. Cronin, M. J Greenway, J. H M Prehn, and O. Hardiman
Paraoxonase promoter and intronic variants modify risk of sporadic amyotrophic lateral sclerosis
J. Neurol. Neurosurg. Psychiatry, September 1, 2007; 78(9): 984 - 986.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
D. Kasperaviciute, M. E. Weale, K. V. Shianna, G. T. Banks, C. L. Simpson, V. K. Hansen, M. R. Turner, C. E. Shaw, A. Al-Chalabi, H. S. Pall, et al.
Large-scale pathways-based association study in amyotrophic lateral sclerosis
Brain, September 1, 2007; 130(9): 2292 - 2301.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
C. E. Shaw and A. Al-Chalabi
Susceptibility genes in sporadic ALS: separating the wheat from the chaff by international collaboration.
Neurology, September 12, 2006; 67(5): 738 - 739.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by AAN Enterprises, Inc.